These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 26993770

  • 1. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
    Tang X, Jin L, Cao P, Cao K, Huang C, Luo Y, Ma J, Shen S, Tan M, Li X, Zhou M.
    Oncotarget; 2016 Apr 26; 7(17):23668-83. PubMed ID: 26993770
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2).
    Liu Y, Gao S, Chen X, Liu M, Mao C, Fang X.
    Tumour Biol; 2016 Sep 26; 37(9):12231-12239. PubMed ID: 27236538
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.
    Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, Xiong W, Li G, Lu J, Fodstad O, Riker AI, Tan M.
    J Biol Chem; 2010 Jul 09; 285(28):21496-507. PubMed ID: 20460378
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.
    Ao X, Nie P, Wu B, Xu W, Zhang T, Wang S, Chang H, Zou Z.
    Cell Death Dis; 2016 Nov 10; 7(11):e2463. PubMed ID: 27831559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis.
    Zhu L, Wang F, Fan W, Jin Z, Teng C, Zhang J.
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug 31; 53(9):1198-1206. PubMed ID: 34327529
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma.
    Huang Y, Chen G, Wang Y, He R, Du J, Jiao X, Tai Q.
    Biochem Biophys Res Commun; 2018 Sep 05; 503(2):1035-1041. PubMed ID: 29935185
    [Abstract] [Full Text] [Related]

  • 9. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y, Qiu Y, Yagüe E, Ji W, Liu J, Zhang J.
    Cell Death Dis; 2016 Jun 30; 7(6):e2291. PubMed ID: 27362808
    [Abstract] [Full Text] [Related]

  • 10. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
    Wu H, Wang G, Wang Z, An S, Ye P, Luo S.
    FEBS J; 2016 Jun 30; 283(12):2259-71. PubMed ID: 26433127
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
    Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, Hu G, Yang Q.
    Oncogene; 2014 Jun 12; 33(24):3119-28. PubMed ID: 23851509
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.
    Dastmalchi N, Safaralizadeh R, Hosseinpourfeizi MA, Baradaran B, Khojasteh SMB.
    Mol Biol Rep; 2021 Feb 12; 48(2):1345-1357. PubMed ID: 33555529
    [Abstract] [Full Text] [Related]

  • 13. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
    Shi Y, Gong W, Lu L, Wang Y, Ren J.
    Braz J Med Biol Res; 2019 Feb 12; 52(11):e8657. PubMed ID: 31664305
    [Abstract] [Full Text] [Related]

  • 14. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
    Luo Y, Wang X, Wang H, Xu Y, Wen Q, Fan S, Zhao R, Jiang S, Yang J, Liu Y, Li X, Xiong W, Ma J, Peng S, Zeng Z, Li X, Phillips JB, Li G, Tan M, Zhou M.
    PLoS One; 2015 Feb 12; 10(9):e0138955. PubMed ID: 26406239
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y, Zhang L, Dong Z, Xu H, Yan L, Wang W, Yang Q, Chen C.
    Pathol Res Pract; 2021 Apr 12; 220():153405. PubMed ID: 33756128
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells.
    Mei M, Ren Y, Zhou X, Yuan XB, Han L, Wang GX, Jia Z, Pu PY, Kang CS, Yao Z.
    Technol Cancer Res Treat; 2010 Feb 12; 9(1):77-86. PubMed ID: 20082533
    [Abstract] [Full Text] [Related]

  • 17. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
    Gan CZ, Li G, Luo QS, Li HM.
    IUBMB Life; 2017 Nov 12; 69(11):841-849. PubMed ID: 28940895
    [Abstract] [Full Text] [Related]

  • 18. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
    Shao B, Wang X, Zhang L, Li D, Liu X, Song G, Cao H, Zhu J, Li H.
    Technol Cancer Res Treat; 2019 Jan 01; 18():1533033819828709. PubMed ID: 30786836
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
    Zhang B, Zhao R, He Y, Fu X, Fu L, Zhu Z, Fu L, Dong JT.
    Oncotarget; 2016 Feb 02; 7(5):5702-14. PubMed ID: 26744318
    [Abstract] [Full Text] [Related]

  • 20. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X, Wang YW, Xing AY, Xiang S, Shi DB, Liu L, Li YX, Gao P.
    J Pathol; 2016 Aug 02; 239(4):459-72. PubMed ID: 27171498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.